§ Mr. du Cann
asked the Parliamentary Secretary for Science what reply he has made to the request of the Pirbright Research Institute for a grant of £100,000 for the development of an anti-foot-and-mouth disease vaccine.
§ Mr. Denzil Freeth
The Governing Body of the Foot-and-Mouth Disease Research Institute, Pirbright, have been authorised to negotiate an agreement with a pharmaceutical firm, the Wellcome Foundation, Ltd., for the production on a commercial scale at Pirbright of foot-and-mouth vaccines for sale abroad. The cost of the buildings required is estimated to amount to about £100,000 and will be eligible for grant-aid from public funds.